BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7541606)

  • 1. Pseudoleukemia following the use of G-CSF.
    Reykdal S; Sham R; Phatak P; Kouides P
    Am J Hematol; 1995 Jul; 49(3):258-9. PubMed ID: 7541606
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudoleukemia after granulocyte colony-stimulating factor therapy.
    Reale MA; Yen Y; Strair RK; Flynn SD; Cooper DL
    South Med J; 1995 Apr; 88(4):462-4. PubMed ID: 7536347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukemogenic risk during long-term use of G-CSF in constitutional neutropenia].
    Donadieu J
    Arch Fr Pediatr; 1993 Nov; 50(9):827. PubMed ID: 7520227
    [No Abstract]   [Full Text] [Related]  

  • 4. Is G-CSF-mobilized peripheral stem cell harvest harmful?
    Donadieu J
    Pediatr Blood Cancer; 2007 May; 48(5):594-5; author reply 595-7. PubMed ID: 16767714
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF: report of two cases.
    Liu CZ; Persad R; Inghirami G; Sen F; Amorosi E; Goldenberg A; Ibrahim S
    Clin Lab Haematol; 2004 Oct; 26(5):359-62. PubMed ID: 15485468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasiform eruption triggered by recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and exacerbated by granulocyte colony stimulating factor (rG-CSF) in a patient with breast cancer.
    Cho SG; Park YM; Moon H; Kim KM; Bae SS; Kim GB; Cho HS; Kim CC; Lee KS
    J Korean Med Sci; 1998 Dec; 13(6):685-8. PubMed ID: 9886182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.
    Li AM; Thyagu S; Maze D; Schreiber R; Sirrs S; Stockler-Ipsiroglu S; Sutherland H; Vercauteren S; Schultz KR
    Pediatr Hematol Oncol; 2018 Feb; 35(1):45-51. PubMed ID: 29652549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage-specific hematopoietic growth factors.
    Ferretti G; Papaldo P; Cognetti F
    N Engl J Med; 2006 Aug; 355(5):526; author reply 527. PubMed ID: 16885561
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F; Ertem U; Taçyildiz N; Kirazli S
    J Med; 1995; 26(5-6):241-52. PubMed ID: 8721901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B; Olofsson T; Lenhoff S
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group.
    Locasciulli A; Arcese W; Locatelli F; Di Bona E; Bacigalupo A;
    Lancet; 2001 Jan; 357(9249):43-4. PubMed ID: 11197365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro growth and clinical response of leukemia cells to macrophage colony-stimulating factor (M-CSF) and granulocyte colony-stimulating factor (G-CSF) in acute leukemia].
    Takeyama H; Kajiguchi T; Miyata Y; Saito M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):873-8. PubMed ID: 10897214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.
    Hermans MH; Antonissen C; Ward AC; Mayen AE; Ploemacher RE; Touw IP
    J Exp Med; 1999 Feb; 189(4):683-92. PubMed ID: 9989983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia.
    Fukutoku M; Shimizu S; Ogawa Y; Takeshita S; Masaki Y; Arai T; Hirose Y; Sugai S; Konda S; Takiguchi T
    Br J Haematol; 1994 Mar; 86(3):645-8. PubMed ID: 7519039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukoerythroblastosis following the use of G-CSF.
    Arici M; Hazendaroğlu IC; Erman M; Ozcebe O
    Am J Hematol; 1996 Jun; 52(2):123-4. PubMed ID: 8638638
    [No Abstract]   [Full Text] [Related]  

  • 20. [The potential prognostic influence of granulocyte-colony stimulating factor in acute leukemia].
    Liu XM; Chen YZ; Huang MJ; Liu X; Guo JR
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):518-21. PubMed ID: 16080844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.